The effect of smoking status on survival following radiation therapy for non-small cell lung cancer Journal Article


Authors: Fox, J. L.; Rosenzweig, K. E.; Ostroff, J. S.
Article Title: The effect of smoking status on survival following radiation therapy for non-small cell lung cancer
Abstract: The dangers of cigarette smoking are numerous and well-known, including the causal relationship to lung cancer. This study investigates the effect that smoking status at initial consultation has on radiation therapy for non-small cell lung cancer (NSCLC). We identified 237 patients treated between 1991 and 2001 with definitive radiation or chemoradiation who had complete smoking histories. Median age was 73, with 56% males. Distribution by stage was as follows: I/II - 27%, IIIA - 27%, IIIB - 45%, recurrent - 1%. Two-year overall survival, stratified by stage of disease, was calculated from the time of initiation of treatment. Median follow-up time from the end of treatment was 13 months. Among those with stage I/II disease, current smokers had a 2-year survival rate of 41% and a median survival of 13.7 months while non-smokers had a 2-year survival of 56% and a median survival of 27.9 months (P=0.01). Patients with stage III disease did not show any significant differences in overall survival. There were no significant differences in cancer-specific survival in either stage. In conclusion, among NSCLC patients diagnosed with early stage disease, current smokers have a poorer prognosis for survival after radiation therapy. © 2003 Elsevier Ireland Ltd. All rights reserved.
Keywords: survival; adult; cancer chemotherapy; cancer survival; controlled study; treatment outcome; aged; middle aged; survival analysis; survival rate; major clinical study; cigarette smoking; cancer patient; cancer radiotherapy; combined modality therapy; cancer staging; follow up; neoplasm staging; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; radiotherapy; smoking; survival time; disease severity; consultation; radiation therapy; platinum derivative; tobacco; non-small cell lung cancer; calculation; humans; prognosis; human; male; female; priority journal; article
Journal Title: Lung Cancer
Volume: 44
Issue: 3
ISSN: 0169-5002
Publisher: Elsevier Ireland Ltd.  
Date Published: 2004-06-01
Start Page: 287
End Page: 293
Language: English
DOI: 10.1016/j.lungcan.2003.11.012
PROVIDER: scopus
PUBMED: 15140541
DOI/URL:
Notes: Lung Cancer -- Cited By (since 1996):40 -- Export Date: 16 June 2014 -- CODEN: LUCAE -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jana Lauren Fox
    7 Fox
  2. Jamie S Ostroff
    344 Ostroff